Singapore markets closed

Synovics Pharmaceuticals, Inc. (SYVC)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 02:10PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 82.37
52-week change 30.00%
S&P500 52-week change 321.83%
52-week high 30.0001
52-week low 30.0001
50-day moving average 30.0001
200-day moving average 30.0001

Share statistics

Avg vol (3-month) 31.66k
Avg vol (10-day) 31.66k
Shares outstanding 536.49M
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Oct 2008
Most-recent quarter (mrq)31 Jul 2009

Profitability

Profit margin -26.42%
Operating margin (ttm)-117.78%

Management effectiveness

Return on assets (ttm)-12.75%
Return on equity (ttm)-314.28%

Income statement

Revenue (ttm)19.09M
Revenue per share (ttm)0.68
Quarterly revenue growth (yoy)-79.50%
Gross profit (ttm)N/A
EBITDA -3.64M
Net income avi to common (ttm)-5.04M
Diluted EPS (ttm)-0.1800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)129.86k
Total cash per share (mrq)0
Total debt (mrq)6.15M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.27
Book value per share (mrq)-0.05

Cash flow statement

Operating cash flow (ttm)1.99M
Levered free cash flow (ttm)-1.33M